Announcements Trials
Browse Landscape

Phase

Phase 2 154Phase 3 71Phase 1/2 31Phase 1 24Phase NA 13Phase 4 10Phase 2/3 9Phase EARLY_PHASE1 3

Status

Completed 4Unknown 3Withdrawn 2Terminated 2Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Tumor-Agnostic 1

Conditions

Pancreatic Neoplasms 2Neoplasms 1

Interventions

fludarabine 17Cyclophosphamide 16Positron Emission Tomography Computed Tomography 4Oncolytic Virotherapy 4Metformin 468Ga-pentixafor 4lenvatinib 3Radiosurgery 3Pemetrexed 3Paclitaxel 3Melphalan 3Immunotherapy, Adoptive 3Gemcitabine 3Cholestanetriol 26-Monooxygenase 3Carboplatin 3toripalimab 2sintilimab 2pembrolizumab 2gallium Ga 68 dotatate 2gallium 68 PSMA-11 2fludarabine phosphate 2alpha-Synuclein 2Progesterone 2Nivolumab 2Neoadjuvant Therapy 2Magnetic Resonance Spectroscopy 2Interleukin-2 2Influenza Vaccines 2Fluorodeoxyglucose F18 2Ethiodized Oil 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Unknown × Gemcitabine × Clear all
NCT02929797 2016-10-11

AKT

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase EARLY_PHASE1 Unknown
72 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02707315 2016-03-14

A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer

The Cooper Health System

Phase EARLY_PHASE1 Unknown
15 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01713218 2012-10-24

NEOPACHI-001

Erasme University Hospital

Phase EARLY_PHASE1 Unknown
21 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡